Cell & Gene Meeting on the Mediterranean (MED)
The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and dedicated presentations by leading publicly traded and privately held companies in the space.
The conference will be delivered in a virtual format over the course of four days – April 6-9, 2021. Registrants will have access to 10+ interactive and on-demand sessions covering a mix of commercialization topics related to the advanced therapy sector including the latest updates on market access and reimbursement schemes, international regulation harmonization, manufacturing and CMC challenges, investment opportunities for the sector, among others. The program will feature 60+ on-demand company presentations by leading public and private companies, highlighting their technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, and tissue engineering. Finally, the meeting will deploy its premier partnering system, partneringONE, allowing registrants to plan 1×1 meetings with other attendees during the event.
See Who’s Presenting
See the list of 80+ companies giving virtual, on-demand presentations at the conference who will also be available for one-on-one partnering throughout the meeting.
Register to Attend
Registration for the meeting is open and virtual pricing is in effect for this year’s program. Secure your spot at the sector’s premier annual conference and register to attend today.
Sponsor the Meeting
Looking for extensive exposure to hundreds of top decision makers in the field? See the list of 2021 supporters and learn more about the meeting’s virtual sponsorship packages.
$100 USD de descuento para socios de AseBio en el registro “Industry & General Admission"